IPO queue swells as Scribe aims to price this week

With six companies joining the queue since July 10 and Scribe Therapeutics aiming to price this week, biotech could be heading for its busiest IPO stretch since late April, when five companies raised about $1.8 billion in aggregate.

Although IPOs have been relatively scarce since early May, with just two biotechs pricing in June, Parabilis Medicines Inc. (NASDAQ:PBLS) raised the largest offering in the sector’s history, drawing $770 million including the greenshoe...